SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-282566
Filing Date
2022-11-10
Accepted
2022-11-10 16:04:03
Documents
46
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d400498d10q.htm   iXBRL 10-Q 683291
2 EX-31.1 d400498dex311.htm EX-31.1 10287
3 EX-31.2 d400498dex312.htm EX-31.2 10304
4 EX-32.1 d400498dex321.htm EX-32.1 3860
5 EX-32.2 d400498dex322.htm EX-32.2 3878
  Complete submission text file 0001193125-22-282566.txt   3668209

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pbax-20220930.xsd EX-101.SCH 41086
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbax-20220930_cal.xml EX-101.CAL 21266
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbax-20220930_def.xml EX-101.DEF 202157
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbax-20220930_lab.xml EX-101.LAB 243243
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbax-20220930_pre.xml EX-101.PRE 237931
40 EXTRACTED XBRL INSTANCE DOCUMENT d400498d10q_htm.xml XML 487810
Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40877 | Film No.: 221376976
SIC: 6770 Blank Checks